HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamide in vitro-Reference-Cited by-同舟云学术

HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamide in vitro

Published:2018-04-12 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Du Zhongbo¹,Li Luo²,Sun Wei¹,Wang Xiao¹,Zhang Yao¹,Chen Zhixiong¹,Yuan Mengjuan¹,Quan Zhen¹,Liu Nanjing²,Hao Yanni²,Li Ting²,Wang Jinhua¹,Luo Chunli²,Wu Xiaohou¹

Affiliation:

1. Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China

2. Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression;Frontiers in Cell and Developmental Biology;2024-07-18

2. Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer;Journal of Clinical Investigation;2024-07-18

3. Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance;Biochemical Pharmacology;2024-02

4. Prostate Cancer Stem Cells: Biology and Treatment Implications;International Journal of Molecular Sciences;2023-10-04

5. Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways (Review);International Journal of Oncology;2023-09-20